Kbc Group Nv Incyte Corp Transaction History

Kbc Group Nv

$43.9 Billion
Q4 2025

A detailed history of Kbc Group Nv transactions in Incyte Corp stock. As of the latest transaction made, Kbc Group Nv holds 267,394 shares of INCY stock, worth $27.8 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

267,394

Previous 425,094 37.1%

Holding current value

$27.8 Million

Previous $36.1 Million 26.74%

% of portfolio

0.06%

Previous 0.09%

46 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2025 Jan 26, 2026	SELL	$83.8 - $108.26 $13.2 Million - $17.1 Million	-157,700 Reduced 37.1%	267,394 $26.4 Million
Q3 2025 Jan 20, 2026	SELL	$67.27 - $86.96 $15.1 Million - $19.6 Million	-224,863 Reduced 34.6%	425,094 $36.1 Million
Q2 2025 Aug 08, 2025	SELL	$55.17 - $71.22 $19.9 Million - $25.7 Million	-361,025 Reduced 35.71%	649,957 $44.3 Million
Q1 2025 Apr 25, 2025	SELL	$60.0 - $75.26 $2.74 Million - $3.44 Million	-45,652 Reduced 4.32%	1,010,982 $61.2 Million
Q4 2024 Jan 22, 2025	SELL	$65.08 - $83.38 $6.8 Million - $8.71 Million	-104,419 Reduced 8.99%	1,056,634 $73 Million

Q3 2024 Nov 06, 2024	SELL	$57.33 - $68.61 $32.3 Million - $38.7 Million	-563,357 Reduced 32.67%	1,161,053 $76.7 Million
Q2 2024 Jul 17, 2024	BUY	$51.18 - $63.75 $9.5 Million - $11.8 Million	185,523 Added 12.06%	1,724,410 $105 Million
Q1 2024 May 08, 2024	BUY	$56.55 - $66.59 $33 Million - $38.8 Million	583,138 Added 61.01%	1,538,887 $87.7 Million
Q4 2023 Feb 13, 2024	BUY	$52.16 - $64.19 $44.6 Million - $54.8 Million	854,311 Added 842.2%	955,749 $60 Million
Q3 2023 Feb 15, 2024	BUY	$57.77 - $65.93 $19.3 Million - $22 Million	334,190 Added 323.33%	437,549 $25.3 Million
Q2 2023 Feb 15, 2024	BUY	$60.95 - $75.51 $5.64 Million - $6.98 Million	92,453 Added 847.73%	103,359 $6.44 Million
Q2 2023 Jul 28, 2023	BUY	$60.95 - $75.51 $4.41 Million - $5.46 Million	72,289 Added 248.0%	101,438 $6.32 Million
Q1 2023 Feb 14, 2024	SELL	$70.23 - $86.01 $351,571 - $430,566	-5,006 Reduced 13.62%	31,741 $2.29 Million
Q1 2023 May 04, 2023	BUY	$70.23 - $86.01 $1.3 Million - $1.59 Million	18,447 Added 172.37%	29,149 $2.11 Million
Q4 2022 Feb 14, 2024	BUY	$67.18 - $84.11 $2.02 Million - $2.53 Million	30,101 Added 452.92%	36,747 $2.95 Million
Q3 2022 Feb 15, 2024	SELL	$66.18 - $82.86 $62.5 Million - $78.3 Million	-944,843 Reduced 98.86%	10,906 $727,000
Q3 2022 Nov 08, 2022	BUY	$66.18 - $82.86 $268,426 - $336,080	4,056 Added 61.03%	10,702 $713,000
Q2 2022 Feb 14, 2024	BUY	$66.18 - $83.18 $25,810 - $32,440	390 Added 6.23%	6,646 $505,000
Q2 2022 Jul 26, 2022	BUY	$66.18 - $83.18 $25,810 - $32,440	390 Added 6.23%	6,646 $505,000
Q1 2022 Feb 14, 2024	SELL	$66.02 - $79.71 $2.79 Million - $3.37 Million	-42,322 Reduced 87.12%	6,256 $497,000
Q1 2022 May 06, 2022	SELL	$66.02 - $79.71 $2.79 Million - $3.37 Million	-42,322 Reduced 87.12%	6,256 $497,000
Q4 2021 Feb 14, 2024	SELL	$63.34 - $74.11 $57.5 Million - $67.2 Million	-907,171 Reduced 94.92%	48,578 $3.57 Million
Q4 2021 Feb 03, 2022	SELL	$63.34 - $74.11 $835,011 - $976,992	-13,183 Reduced 21.35%	48,578 $3.57 Million
Q3 2021 Nov 10, 2021	SELL	$68.67 - $84.02 $1.18 Million - $1.44 Million	-17,117 Reduced 21.7%	61,761 $4.25 Million
Q2 2021 Aug 11, 2021	SELL	$79.87 - $87.53 $1.25 Million - $1.37 Million	-15,658 Reduced 16.56%	78,878 $6.64 Million
Q1 2021 Apr 26, 2021	BUY	$76.02 - $100.5 $57,471 - $75,978	756 Added 0.81%	94,536 $7.68 Million
Q4 2020 Feb 10, 2021	SELL	$80.74 - $97.7 $296,073 - $358,265	-3,667 Reduced 3.76%	93,780 $8.16 Million
Q3 2020 Oct 28, 2020	SELL	$85.07 - $109.69 $1.93 Million - $2.49 Million	-22,720 Reduced 18.91%	97,447 $8.75 Million
Q2 2020 Aug 10, 2020	BUY	$74.18 - $108.93 $6.75 Million - $9.91 Million	90,968 Added 311.54%	120,167 $12.5 Million
Q1 2020 May 04, 2020	SELL	$63.18 - $85.97 $5.71 Million - $7.77 Million	-90,361 Reduced 75.58%	29,199 $2.14 Million
Q4 2019 Feb 11, 2020	SELL	$73.04 - $95.72 $540,715 - $708,615	-7,403 Reduced 5.83%	119,560 $10.4 Million
Q3 2019 Nov 07, 2019	BUY	$72.82 - $86.52 $9.23 Million - $11 Million	126,803 Added 79251.88%	126,963 $0
Q2 2019 Dec 03, 2019	SELL	$73.52 - $88.7 $8.86 Million - $10.7 Million	-120,476 Reduced 99.87%	160 $14,000
Q2 2019 Jul 30, 2019	BUY	$73.52 - $88.7 $8.86 Million - $10.7 Million	120,476 Added 75297.5%	120,636 $0
Q1 2019 Dec 03, 2019	SELL	$63.56 - $88.17 $7.07 Million - $9.8 Million	-111,159 Reduced 99.86%	160 $14,000
Q1 2019 May 10, 2019	BUY	$63.56 - $88.17 $7.07 Million - $9.8 Million	111,159 Added 69474.38%	111,319 $0
Q4 2018 Dec 03, 2019	SELL	$58.5 - $69.94 $16.9 Million - $20.2 Million	-289,381 Reduced 99.94%	160 $10,000
Q4 2018 Jan 31, 2019	BUY	$58.5 - $69.94 $16.9 Million - $20.2 Million	289,381 Added 180863.12%	289,541 $0
Q3 2018 Dec 03, 2019	SELL	$61.75 - $74.23 $19.4 Million - $23.3 Million	-313,577 Reduced 99.95%	160 $11,000
Q3 2018 Nov 14, 2018	BUY	$61.75 - $74.23 $19.4 Million - $23.3 Million	313,577 Added 195985.62%	313,737 $0
Q2 2018 Dec 03, 2019	SELL	$60.85 - $83.98 $11.3 Million - $15.6 Million	-185,842 Reduced 99.91%	160 $11,000
Q2 2018 Aug 03, 2018	BUY	$60.85 - $83.98 $11.3 Million - $15.6 Million	185,842 Added 116151.25%	186,002 $0
Q1 2018 Dec 03, 2019	SELL	$83.06 - $100.98 $1.47 Million - $1.79 Million	-17,682 Reduced 99.1%	160 $13,000
Q1 2018 May 09, 2018	SELL	$83.06 - $100.98 $211,636 - $257,297	-2,548 Reduced 12.5%	17,842 $0
Q4 2017 Feb 07, 2018	SELL	$93.56 - $116.6 $194,417 - $242,294	-2,078 Reduced 9.25%	20,390 $0
Q3 2017 Nov 13, 2017	BUY	$109.15 - $138.27 $2.45 Million - $3.11 Million	22,468	22,468 $0

Others Institutions Holding INCY

# of Institutions

832

Shares Held

205M

Call Options Held

641K

Put Options Held

635K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $23.2B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

News

Stay updated on Kbc Group Nv with notifications on news.

Account